{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:59:14Z","timestamp":1782604754868,"version":"3.54.5"},"reference-count":226,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDDT"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>More than two hundred years ago, taurine was first isolated from materials derived from animals.\nIt is abundantly found in a wide range of mammalian and non-mammalian tissues and diverse\nenvironments. Taurine was discovered to be a by-product of the metabolism of sulfur only a little over\na century and a half ago. Recently, there has been a renewed academic interest in researching and exploring\nvarious uses of the amino acid taurine, and recent research has indicated that it may be useful\nin the treatment of a variety of disorders, including seizures, high blood pressure, cardiac infarction,\nneurodegeneration, and diabetes. Taurine is currently authorised for the therapy of congestive heart\nfailure in Japan, and it has shown promising results in the management of several other illnesses as\nwell. Moreover, it was found to be effective in some clinical trials, and hence it was patented for the\nsame. This review compiles the research data that supports the prospective usage of taurine as an antibacterial,\nantioxidant, anti-inflammatory, diabetic, retinal protective, and membrane stabilizing agent,\namongst other applications.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570163820666230525101353","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T06:18:03Z","timestamp":1685081883000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Biological Effects and Mechanisms of Taurine in Various Therapeutics"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9717-7819","authenticated-orcid":true,"given":"Shikha","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Science Lords University Alwar-301028, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswa Mohan","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy,\nRoland Institute of Pharmaceutical Sciences, Berhampur-760010, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7873-9062","authenticated-orcid":true,"given":"Bimal Krishna","family":"Banik","sequence":"additional","affiliation":[{"name":"Department of Chemistry, College of\nSciences and Human Studies, Prince Mohammad Bin Fahd University, Al Khobar, Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/jsfa.2740040502","volume":"4","author":"Bathurst N.O.","year":"1953","unstructured":"Bathurst N.O.; The free amino-acids and peptides of plant tissues. J Sci Food Agric 1953,4(5),221-226","journal-title":"J Sci Food Agric"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0300-9629(82)90098-6","volume":"73","author":"Reynoso G.T.","year":"1982","unstructured":"Reynoso G.T.; de Gamboa B.A.; Salt tolerance in the freshwater algae Chlamydomon as reinhardii: Effect of proline and taurine. Comp Biochem Physiol A Comp Physiol 1982,73(1),95-99","journal-title":"Comp Biochem Physiol A Comp Physiol"},{"key":"ref=3","first-page":"50957","volume":"61","year":"1986","unstructured":"Jpn Kokai Tokyo Koho 1986,61,50957"},{"key":"ref=4","first-page":"270","volume":"27","author":"Demarcay H.","year":"1938","unstructured":"Demarcay H.; Ueber die Natur der Galle Ann. Pharm 1938,27,270-291","journal-title":"Pharm"},{"key":"ref=5","first-page":"5","author":"Huxtable R.","year":"1983","unstructured":"Huxtable R.; Iwata H.;  Sulfur Amino Acids Biochemical Aspects 1983,5-37","journal-title":"Sulfur Amino Acids Biochemical Aspects"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"S1636","DOI":"10.1093\/jn\/136.6.1636S","volume":"136","author":"Brosnan J.T.","year":"2006","unstructured":"Brosnan J.T.; Brosnan M.E.; The sulfur-containing amino acids: An overview. J Nutr 2006,136(6)(Suppl.),S1636-S1640","journal-title":"J Nutr"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5564\/mjc.v14i0.200","volume":"14","author":"Bayarmaa B.","year":"2014","unstructured":"Bayarmaa B.; Otgonsuren D.; Odonmajig P.; Synthesis and characterization of Taurine. Mongolian J Chem 2014,14,57-60","journal-title":"Mongolian J Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/BF01973715","volume":"65","author":"Waterfield C.J.","year":"1991","unstructured":"Waterfield C.J.; Turton J.A.; Scales M.D.C.; Timbrell J.A.; Taurine, a possible urinary marker of liver damage: A study of taurine excretion in carbon tetrachloride-treated rats. Arch Toxicol 1991,65(7),548-555","journal-title":"Arch Toxicol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1107\/S0365110X66003785","volume":"21","author":"Okaya Y.","year":"1996","unstructured":"Okaya Y.; Refinement of the crystal structure of taurine, 2-amino-ethylsulfonic acid an example of computer-controlled experimentation. Acta Crystallogr 1996,21,726-729","journal-title":"Acta Crystallogr"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1152\/physrev.1968.48.2.424","volume":"48","author":"Jacobsen J.G.","year":"1968","unstructured":"Jacobsen J.G.; Smith L.H.; Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev 1968,48(2),424-511","journal-title":"Physiol Rev"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1471-4159.1985.tb12878.x","volume":"44","author":"Marnela K.M.","year":"1985","unstructured":"Marnela K.M.; Morris H.R.; Panico M.; Timonen M.; L\u00e4hdesm\u00e4ki P.; Glutamyl-taurine is the predominant synaptic taurine peptide. J Neurochem 1985,44(3),752-754","journal-title":"J Neurochem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-1-4757-4448-4_9","volume":"3","author":"Sturman J.A.","year":"1980","unstructured":"Sturman J.A.; Hayes K.C.; The biology of taurine in nutrition and development. Adv Nutr Res 1980,3,231-299","journal-title":"Adv Nutr Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1138364","volume":"188","author":"Hayes K.C.","year":"1975","unstructured":"Hayes K.C.; Carey R.E.; Schmidt S.Y.; Retinal degeneration associated with taurine deficiency in the cat. Science 1975,188(4191),949-951","journal-title":"Science"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1146\/annurev.me.18.020167.002001","volume":"18","author":"Hofmann A.F.","year":"1967","unstructured":"Hofmann A.F.; Small D.M.; Detergent properties of bile salts: Correlation with physiological function. Annu Rev Med 1967,18(1),333-376","journal-title":"Annu Rev Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/0024-3205(80)90358-6","volume":"26","author":"Thurston J.H.","year":"1980","unstructured":"Thurston J.H.; Hauhart R.E.; Dirgo J.A.; Taurine: A role in osmotic regulation of mammalian brain and possible clinical significance. Life Sci 1980,26(19),1561-1568","journal-title":"Life Sci"},{"key":"ref=16","first-page":"445","volume":"232","author":"Sebring L.A.","year":"1985","unstructured":"Sebring L.A.; Huxtable R.J.; Taurine modulation of calcium binding to cardiac sarcolemma. J Pharmacol Exp Ther 1985,232(2),445-451","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=17","first-page":"297","volume":"125","author":"Gaull G.E.","year":"1983","unstructured":"Gaull G.E.; Wright C.E.; Tallan H.H.; Taurine in human lymphoblastoid cells: Uptake and role in proliferation. Prog Clin Biol Res 1983,125,297-303","journal-title":"Prog Clin Biol Res"},{"key":"ref=18","first-page":"153","volume":"35","author":"Bernardi N.","year":"1985","unstructured":"Bernardi N.; On the role of taurine in the cerebellar cortex: A reappraisal. Acta Physiol Pharmacol Latinoam 1985,35(2),153-164","journal-title":"Acta Physiol Pharmacol Latinoam"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1016\/0006-2952(84)90204-1","volume":"33","author":"Kulakowski E.C.","year":"1984","unstructured":"Kulakowski E.C.; Maturo J.; Hypoglycemic properties of taurine: Not mediated by enhanced insulin release. Biochem Pharmacol 1984,33(18),2835-2838","journal-title":"Biochem Pharmacol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/00498258309052246","volume":"13","author":"Emudianughe T.S.","year":"1983","unstructured":"Emudianughe T.S.; Caldwell J.; Smith R.L.; The utilization of exogenous taurine for the conjugation of xenobiotic acids in the ferret. Xenobiotica 1983,13(3),133-138","journal-title":"Xenobiotica"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-94-024-1079-2_21","volume":"975","author":"Jang H.","year":"2017","unstructured":"Jang H.; Lee S.; Choi S.L.; Kim H.Y.; Baek S.; Kim Y.; Taurine directly binds to oligomeric amyloid-\u03b2 and recovers cognitive deficits in Alzheimer model mice. Adv Exp Med Biol 2017,975(Pt 1),233-241","journal-title":"Adv Exp Med Biol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41419-018-0468-2","volume":"9","author":"Che Y.","year":"2018","unstructured":"Che Y.; Hou L.; Sun F.; Taurine protects dopaminergic neurons in a mouse Parkinson\u2019s disease model through inhibition of microglial M1 polarization. Cell Death Dis 2018,9(4),435","journal-title":"Cell Death Dis"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.pbb.2005.10.018","volume":"82","author":"Tadros M.G.","year":"2005","unstructured":"Tadros M.G.; Khalifa A.E.; Abdel-Naim A.B.; Arafa H.M.M.; Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington\u2019s disease phenotype. Pharmacol Biochem Behav 2005,82(3),574-582","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1016\/0006-2952(85)90419-8","volume":"34","author":"Pasantes-Morales H.","year":"1985","unstructured":"Pasantes-Morales H.; Wright C.E.; Gaull G.E.; Taurine protection of lymphoblastoid cells from iron-ascorbate induced damage. Biochem Pharmacol 1985,34(12),2205-2207","journal-title":"Biochem Pharmacol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","volume":"72","author":"Russell D.W.","year":"2003","unstructured":"Russell D.W.; The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 2003,72(1),137-174","journal-title":"Annu Rev Biochem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1161\/HYPERTENSIONAHA.115.06624","volume":"67","author":"Sun Q.","year":"2016","unstructured":"Sun Q.; Wang B.; Li Y.; Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension. Hypertension 2016,67(3),541-549","journal-title":"Hypertension"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0002-8703(92)90644-B","volume":"123","author":"Milei J.","year":"1992","unstructured":"Milei J.; Ferreira R.; Llesuy S.; Forcada P.; Covarrubias J.; Boveris A.; Reduction of reperfusion injury with preoperative rapid intravenous infusion of taurine during myocardial revascularization. Am Heart J 1992,123(2),339-345","journal-title":"Am Heart J"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3390\/ijms19041088","volume":"19","author":"Guzzetti S.","year":"2018","unstructured":"Guzzetti S.; Calzari L.; Buccarello L.; Taurine administration recovers motor and learning deficits in an angelman syndrome mouse model. Int J Mol Sci 2018,19(4),1088","journal-title":"Int J Mol Sci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s00726-017-2462-x","volume":"49","author":"Zhang Q.","year":"2017","unstructured":"Zhang Q.; Liu Y.; Wang H.; The preventive effects of taurine on neural tube defects through the Wnt\/PCP-Jnk-dependent pathway. Amino Acids 2017,49(9),1633-1640","journal-title":"Amino Acids"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/978-1-4899-1471-2_46","volume":"359","author":"Azuma J.","year":"1994","unstructured":"Azuma J.; Long-term effect of taurine in congestive heart failure: Preliminary report. Adv Exp Med Biol 1994,359,425-433","journal-title":"Adv Exp Med Biol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00726-017-2529-8","volume":"50","author":"Zhao H.","year":"2018","unstructured":"Zhao H.; Qu J.; Li Q.; Taurine supplementation reduces neuroinflammation and protects against white matter injury after intracerebral hemorrhage in rats. Amino Acids 2018,50(3-4),439-451","journal-title":"Amino Acids"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-1-4615-3436-5_39","volume":"315","author":"Giri S.N.","year":"1992","unstructured":"Giri S.N.; Wang Q.; Taurine and niacin offer a novel therapeutic modality in prevention of chemically-induced pulmonary fibrosis in hamsters. Adv Exp Med Biol 1992,315,329-340","journal-title":"Adv Exp Med Biol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00726-021-03041-4","volume":"53","author":"De Carvalho F.G.","year":"2021","unstructured":"De Carvalho F.G.; Brandao C.F.C.; Mu\u00f1oz V.R.; Taurine supplementation in conjunction with exercise modulated cytokines and improved subcutaneous white adipose tissue plasticity in obese women. Amino Acids 2021,53(9),1391-1403","journal-title":"Amino Acids"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4062\/biomolther.2010.18.1.024","volume":"18","author":"Yeon J.A.","year":"2010","unstructured":"Yeon J.A.; Kim S.J.; Neuroprotective Effect of Taurine against Oxidative Stress-Induced Damages in Neuronal Cells. Biomol Ther 2010,18(1),24-31","journal-title":"Biomol Ther"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/neu.2009.1044","volume":"27","author":"Nakajima Y.","year":"2010","unstructured":"Nakajima Y.; Osuka K.; Seki Y.; Taurine reduces inflammatory responses after spinal cord injury. J Neurotrauma 2010,27(2),403-410","journal-title":"J Neurotrauma"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2009.06.002","volume":"208","author":"W\u00f3jcik O.P.","year":"2010","unstructured":"W\u00f3jcik O.P.; Koenig K.L.; Zeleniuch-Jacquotte A.; Costa M.; Chen Y.; The potential protective effects of taurine on coronary heart disease. Atherosclerosis 2010,208(1),19-25","journal-title":"Atherosclerosis"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1073\/pnas.79.8.2695","volume":"79","author":"Chan-Palay V.","year":"1982","unstructured":"Chan-Palay V.; Lin C.T.; Palay S.; Yamamoto M.; Wu J.Y.; Taurine in the mammalian cerebellum: Demonstration by autoradiography with [ 3 H]taurine and immunocytochemistry with antibodies against the taurine-synthesizing enzyme, cysteine-sulfinic acid decarboxylase. Proc Natl Acad Sci USA 1982,79(8),2695-2699","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/syn.890040107","volume":"4","author":"Magnusson K.R.","year":"1989","unstructured":"Magnusson K.R.; Clements J.R.; Wu J.Y.; Beitz A.J.; Colocalization of taurine- and cysteine sulfinic acid decarboxylase-like immunoreactivity in the hippocampus of the rat. Synapse 1989,4(1),55-69","journal-title":"Synapse"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3390\/ph5101128","volume":"5","author":"Chung M.","year":"2012","unstructured":"Chung M.; Malatesta P.; Bosquesi P.; Yamasaki P.; Santos J.L.; Vizioli E.; Advances in drug design based on the amino Acid approach: Taurine analogues for the treatment of CNS diseases. Pharmaceuticals 2012,5(10),1128-1146","journal-title":"Pharmaceuticals"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00726-003-0059-z","volume":"26","author":"Zhang M.","year":"2004","unstructured":"Zhang M.; Bi L.F.; Fang J.H.; Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. Amino Acids 2004,26(3),267-271","journal-title":"Amino Acids"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/jn\/122.1.82","volume":"122","author":"Sturman J.A.","year":"1992","unstructured":"Sturman J.A.; Messing J.M.; High dietary taurine effects on feline tissue taurine concentrations and reproductive performance. J Nutr 1992,122(1),82-88","journal-title":"J Nutr"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/0006-3002(62)90357-8","volume":"63","author":"Sumizu K.","year":"1962","unstructured":"Sumizu K.; Oxidation of hypotaurine in rat liver. Biochim Biophys Acta 1962,63(1),210-212","journal-title":"Biochim Biophys Acta"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/0304-4165(81)90246-4","volume":"677","author":"Oja S.S.","year":"1981","unstructured":"Oja S.S.; Kontro P.; Oxidation of hypotaurine in vitro by mouse liver and brain tissues. Biochim Biophys Acta, Gen Subj 1981,677(3-4),350-357","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/0301-0082(89)90019-1","volume":"32","author":"Huxtable R.J.","year":"1989","unstructured":"Huxtable R.J.; Taurine in the central nervous system and the mammalian actions of taurine. Prog Neurobiol 1989,32(6),471-533","journal-title":"Prog Neurobiol"},{"key":"ref=45","first-page":"204","volume":"23","author":"Fiori A.","year":"1969","unstructured":"Fiori A.; Costa M.; Ossidazione della ipotaurina con H2O2. Acta Vitaminol Enzymol 1969,23(6),204-207","journal-title":"Acta Vitaminol Enzymol"},{"key":"ref=46","first-page":"435","volume":"10","author":"Ricci G.","year":"1978","unstructured":"Ricci G.; Dupr\u00e9 S.; Federici G.; Spoto G.; Matarese R.M.; Cavallini D.; Oxidation of hypotaurine to taurine by ultraviolet irradiation. Physiol Chem Phys 1978,10(5),435-441","journal-title":"Physiol Chem Phys"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-4899-0405-8_4","volume":"217","author":"Fellman J.H.","year":"1987","unstructured":"Fellman J.H.; Green T.R.; Eicher A.L.; The oxidation of hypotaurine to taurine: Bis-aminoethyl-alpha-disulfone, a metabolic intermediate in mammalian tissue. Adv Exp Med Biol 1987,217,39-48","journal-title":"Adv Exp Med Biol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1099\/mic.0.26089-0","volume":"149","author":"Barnett J.A.","year":"2003","unstructured":"Barnett J.A.; Beginnings of microbiology and biochemistry: The contribution of yeast research. Microbiology 2003,149(3),557-567","journal-title":"Microbiology"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.freeradbiomed.2005.08.019","volume":"40","author":"Peskin A.V.","year":"2006","unstructured":"Peskin A.V.; Winterbourn C.C.; Taurine chloramine is more selective than hypochlorous acid at targeting critical cysteines and inactivating creatine kinase and glyceraldehyde-3-phosphate dehydrogenase. Free Radic Biol Med 2006,40(1),45-53","journal-title":"Free Radic Biol Med"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1021\/ja01202a511","volume":"69","author":"Rapport M.M.","year":"1947","unstructured":"Rapport M.M.; Mead J.F.; Maynard J.T.; Senear A.E.; Koepfli J.B.; Derivatives of Taurine and \u03b2-Alanine. J Am Chem Soc 1947,69(10),2561-2563","journal-title":"J Am Chem Soc"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4269\/ajtmh.1987.37.106","volume":"37","author":"Yazdanbakhsh M.","year":"1987","unstructured":"Yazdanbakhsh M.; Roos D.; Eckmann C.M.; Killing of schistosomula by taurine chloramine and taurine bromamine. Am J Trop Med Hyg 1987,37(1),106-110","journal-title":"Am J Trop Med Hyg"},{"key":"ref=52","first-page":"106","volume":"37","author":"Nagl M.","year":"2000","unstructured":"Nagl M.; Hess M.W.; Pfaller K.; Hengster P.; Gottardi W.; Activity of Micromolar N-Chlorotaurine: Evidence for its antimicrobial function in the human defense system. Antimicrob Agents Chem 2000,37,106-110","journal-title":"Antimicrob Agents Chem"},{"key":"ref=53","first-page":"69","volume":"1","author":"Islambulchilar M.","year":"2011","unstructured":"Islambulchilar M.; Sattari M.R.; Sardashti M.; Lotfipour F.; Effect of Taurine on the antimicrobial efficiency of Gentamicin. Adv Pharm Bull 2011,1(2),69-74","journal-title":"Adv Pharm Bull"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-3-319-15126-7_11","volume":"803","author":"Strus M.","year":"2015","unstructured":"Strus M.; Walczewska M.; Machul A.; Miko\u0142ajczyk D.; Marcinkiewicz J.; Taurine haloamines and biofilm. part i: antimicrobial activity of taurine bromamine and chlorhexidine against biofilm forming Pseudomonas aeruginosa. Adv Exp Med Biol 2015,803,121-132","journal-title":"Adv Exp Med Biol"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.18596\/jotcsa.834579","volume":"8","author":"Akg\u00fcl O.","year":"2021","unstructured":"Akg\u00fcl O.; Ate\u015f A.; Ermertcan S.; Activity Evalution of Newly Synthesized N,N-Disubstituted Taurin amido benzenesulfonamide Derivative. J Turkish Chem Soc Sect A: Chem 2021,8(1),321-328","journal-title":"J Turkish Chem Soc Sect A: Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1042\/bj2560251","volume":"256","author":"Aruoma O.I.","year":"1988","unstructured":"Aruoma O.I.; Halliwell B.; Hoey B.M.; Butler J.; The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J 1988,256(1),251-255","journal-title":"Biochem J"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"260114339","DOI":"10.1016\/j.anifeedsci.2019.114339","author":"Surai P.F.","year":"2020","unstructured":"Surai P.F.; Kochish I.I.; Kidd M.T.; Taurine in poultry nutrition. Anim Feed Sci Technol 2020,260114339","journal-title":"Anim Feed Sci Technol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3892\/mmr.2021.12242","volume":"24","author":"Baliou S.","year":"2021","unstructured":"Baliou S.; Adamaki M.; Ioannou P.; Protective role of taurine against oxidative stress.(Review). Mol Med Rep 2021,24(2),605","journal-title":"Mol Med Rep"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/abbs\/gmv109","volume":"47","author":"Bosevski M.","year":"2015","unstructured":"Bosevski M.; Stojanovska L.; Apostolopoulos V.; Inflammatory biomarkers: Impact for diabetes and diabetic vascular disease. Acta Biochim Biophys Sin 2015,47(12),1029-1031","journal-title":"Acta Biochim Biophys Sin"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.etp.2004.08.004","volume":"56","author":"Hanna J.","year":"2004","unstructured":"Hanna J.; Chahine R.; Aftimos G.; Protective effect of taurine against free radicals damage in the rat myocardium. Exp Toxicol Pathol 2004,56(3),189-194","journal-title":"Exp Toxicol Pathol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1006\/exer.1999.0697","volume":"69","author":"Kilic F.","year":"1999","unstructured":"Kilic F.; Bhardwaj R.; Caulfeild J.; Trevithick J.R.; Modelling cortical cataractogenesis 22: Is in vitro reduction of damage in model diabetic rat cataract by taurine due to its antioxidant activity? Exp Eye Res 1999,69(3),291-300","journal-title":"Exp Eye Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1734-1140(10)70256-5","volume":"62","author":"Oliveira M.W.S.","year":"2010","unstructured":"Oliveira M.W.S.; Minotto J.B.; de Oliveira M.R.; Scavenging and antioxidant potential of physiological taurine concentrations against different reactive oxygen\/nitrogen species. Pharmacol Rep 2010,62(1),185-193","journal-title":"Pharmacol Rep"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/0-306-46838-7_40","volume":"483","author":"Messina S.A.","year":"2002","unstructured":"Messina S.A.; Dawson R.; Attenuation of oxidative damage to DNA by taurine and taurine analogs. Adv Exp Med Biol 2002,483,355-367","journal-title":"Adv Exp Med Biol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/978-0-387-33504-9_52","volume":"583","author":"Gupta R.C.","year":"2006","unstructured":"Gupta R.C.; Taurine analogues and taurine transport: Therapeutic advantages. Adv Exp Med Biol 2006,583,449-467","journal-title":"Adv Exp Med Biol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"Lin M.T.","year":"2006","unstructured":"Lin M.T.; Beal M.F.; Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006,443(7113),787-795","journal-title":"Nature"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbagen.2014.10.012","volume":"1850","author":"Sekine S.","year":"2015","unstructured":"Sekine S.; Ichijo H.; Mitochondrial proteolysis: Its emerging roles in stress responses. Biochim Biophys Acta, Gen Subj 2015,1850(2),274-280","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","volume":"122","author":"Forrester S.J.","year":"2018","unstructured":"Forrester S.J.; Kikuchi D.S.; Hernandes M.S.; Xu Q.; Griendling K.K.; Reactive Oxygen Species in Metabolic and Inflammatory Signaling. Circ Res 2018,122(6),877-902","journal-title":"Circ Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"BSR20171492","DOI":"10.1042\/BSR20171492","volume":"38","author":"Larosa V.","year":"2018","unstructured":"Larosa V.; Remacle C.; Insights into the respiratory chain and oxidative stress. Biosci Rep 2018,38(5),BSR20171492","journal-title":"Biosci Rep"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1093\/emboj\/cdf656","volume":"21","author":"Suzuki T.","year":"2002","unstructured":"Suzuki T.; Suzuki T.; Wada T.; Saigo K.; Watanabe K.; Taurine as a constituent of mitochondrial tRNAs: New insights into the functions of taurine and human mitochondrial diseases. EMBO J 2002,21(23),6581-6589","journal-title":"EMBO J"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"15070","DOI":"10.1073\/pnas.0405173101","volume":"101","author":"Kirino Y.","year":"2004","unstructured":"Kirino Y.; Yasukawa T.; Ohta S.; Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. Proc Natl Acad Sci 2004,101(42),15070-15075","journal-title":"Proc Natl Acad Sci"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/jnr.490110310","volume":"11","author":"Pasantes-Morales H.","year":"1984","unstructured":"Pasantes-Morales H.; Cruz C.; Protective effect of taurine and zinc on peroxidation-induced damage in photoreceptor outer segments. J Neurosci Res 1984,11(3),303-311","journal-title":"J Neurosci Res"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/01.mco.0000247469.26414.55","volume":"9","author":"Bouckenooghe T.","year":"2006","unstructured":"Bouckenooghe T.; Remacle C.; Reusens B.; Is taurine a functional nutrient? Curr Opin Clin Nutr Metab Care 2006,9(6),728-733","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1152\/physrev.1992.72.1.101","volume":"72","author":"Huxtable R.J.","year":"1992","unstructured":"Huxtable R.J.; Physiological actions of taurine. Physiol Rev 1992,72(1),101-163","journal-title":"Physiol Rev"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/jlb.47.4.321","volume":"47","author":"Schuller-Levis G.","year":"1990","unstructured":"Schuller-Levis G.; Mehta P.D.; Rudelli R.; Sturman J.; Immunologic consequences of taurine deficiency in cats. J Leukoc Biol 1990,47(4),321-331","journal-title":"J Leukoc Biol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0009-3084(87)90068-5","volume":"45","author":"Clemens M.R.","year":"1987","unstructured":"Clemens M.R.; Waller H.D.; Lipid peroxidation in erythrocytes. Chem Phys Lipids 1987,45(2-4),251-268","journal-title":"Chem Phys Lipids"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1056\/NEJM198902093200606","volume":"320","author":"Epstein F.H.","year":"1989","unstructured":"Epstein F.H.; Weiss S.J.; Tissue destruction by neutrophils. N Engl J Med 1989,320(6),365-376","journal-title":"N Engl J Med"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1172\/JCI103461","volume":"36","author":"Beutler E.","year":"1957","unstructured":"Beutler E.; Robson M.; Buttenwieser E.; The mechanism of glutathione destruction and protection in drug-sensitive and non-sensitive erythrocytes; in vitro studies. J Clin Invest 1957,36(4),617-628","journal-title":"J Clin Invest"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1139\/Y08-110","volume":"87","author":"Schaffer S.W.","year":"2009","unstructured":"Schaffer S.W.; Azuma J.; Mozaffari M.; Role of antioxidant activity of taurine in diabetesThis article is one of a selection of papers from the NATO Advanced Research Workshop on Translational Knowledge for Heart Health (published in part 1 of a 2-part Special Issue). Can J Physiol Pharmacol 2009,87(2),91-99","journal-title":"Can J Physiol Pharmacol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ejphar.2009.05.027","volume":"616","author":"Wang L.","year":"2009","unstructured":"Wang L.; Na, Zhao.; Fang Zhang, Wang Yue Liang M. Effect of taurine on leukocyte function. Eur J Pharmacol 2009,616,275-280","journal-title":"Eur J Pharmacol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/jlb.61.2.161","volume":"61","author":"Park E.","year":"1997","unstructured":"Park E.; Schuller-Levis G.; Jia J.H.; Quinn M.R.; Preactivation exposure of RAW 264.7 cells to taurine chloramine attenuates subsequent production of nitric oxide and expression of iNOS mRNA. J Leukoc Biol 1997,61(2),161-166","journal-title":"J Leukoc Biol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0304-4165(91)90187-L","volume":"1073","author":"Green T.R.","year":"1991","unstructured":"Green T.R.; Fellman J.H.; Eicher A.L.; Pratt K.L.; Antioxidant role and subcellular location of hypotaurine and taurine in human neutrophils. Biochim Biophys Acta, Gen Subj 1991,1073(1),91-97","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/jlb.54.2.119","volume":"54","author":"Park E.","year":"1993","unstructured":"Park E.; Quinn M.R.; Wright C.E.; Schuller-Levis G.; Taurine chloramine inhibits the synthesis of nitric oxide and the release of tumor necrosis factor in activated RAW 264.7 cells. J Leukoc Biol 1993,54(2),119-124","journal-title":"J Leukoc Biol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.4049\/jimmunol.167.4.2275","volume":"167","author":"Barua M.","year":"2001","unstructured":"Barua M.; Liu Y.; Quinn M.R.; Taurine chloramine inhibits inducible nitric oxide synthase and TNF-alpha gene expression in activated alveolar macrophages: Decreased NF-kappaB activation and IkappaB kinase activity. J Immunol 2001,167(4),2275-2281","journal-title":"J Immunol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/0-306-46838-7_56","volume":"483","author":"Pokhrel P.K.","year":"2002","unstructured":"Pokhrel P.K.; Lau-Cam C.A.; In vitro and in vivo effects of taurine and structurally related sulfur-containing compounds against phenylhydrazine-induced oxidative damage to erythrocytes. Adv Exp Med Biol 2002,483,503-522","journal-title":"Adv Exp Med Biol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1126\/science.3616607","volume":"237","author":"Pion P.D.","year":"1987","unstructured":"Pion P.D.; Kittleson M.D.; Rogers Q.R.; Morris J.G.; Myocardial failure in cats associated with low plasma taurine: A reversible cardiomyopathy. Science 1987,237(4816),764-768","journal-title":"Science"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1939-1676.1997.tb00092.x","volume":"11","author":"Kittleson M.D.","year":"1997","unstructured":"Kittleson M.D.; Keene B.; Pion P.D.; Loyer C.G.; Results of the multicenter spaniel trial (MUST): Taurine- and carnitine-responsive dilated cardiomyopathy in American cocker spaniels with decreased plasma taurine concentration. J Vet Intern Med 1997,11(4),204-211","journal-title":"J Vet Intern Med"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/0002-8703(91)90724-V","volume":"121","author":"Moise N.S.","year":"1991","unstructured":"Moise N.S.; Pacioretty L.M.; Kallfelz F.A.; Stipanuk M.H.; King J.M.; Gilmour R.F.; Dietary taurine deficiency and dilated cardiomyopathy in the fox. Am Heart J 1991,121(2),541-547","journal-title":"Am Heart J"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/978-1-4899-0117-0_54","author":"Lombardini J.B.","year":"1998","unstructured":"Lombardini J.B.; Increased phosphorylation of specific rat cardiac and retinal proteins in taurine-depleted animals: Isolation and identification of the phosphoproteins. Taurine 3 1998,441-447","journal-title":"Taurine 3"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/0006-2952(86)90087-0","volume":"35","author":"Mozaffari M.S.","year":"1986","unstructured":"Mozaffari M.S.; Tan B.H.; Lucia M.A.; Schaffer S.W.; Effect of drug-induced taurine depletion on cardiac contractility and metabolism. Biochem Pharmacol 1986,35(6),985-989","journal-title":"Biochem Pharmacol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-4899-1471-2_2","volume":"359","author":"Lombardini J.B.","year":"1994","unstructured":"Lombardini J.B.; The inhibitory effects of taurine on protein phosphorylation: Comparison of various characteristics of the taurine-affected phosphoproteins present in rat retina, brain and heart. Adv Exp Med Biol 1994,359,9-17","journal-title":"Adv Exp Med Biol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1001\/jama.296.15.1885","volume":"296","author":"Mozaffarian D.","year":"2006","unstructured":"Mozaffarian D.; Rimm E.B.; Fish intake, contaminants, and human health: Evaluating the risks and the benefits. JAMA 2006,296(15),1885-1899","journal-title":"JAMA"},{"key":"ref=92","author":"Yamori Y.","year":"1965","unstructured":"Yamori Y.; Nara Y.; Ikeda K.; Mizushima S.;  Is taurine a preventive nutritionTaurine 2 1965","journal-title":"Is taurine a preventive nutritionTaurine 2"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ejphar.2007.10.039","volume":"580","author":"Niu L.G.","year":"2008","unstructured":"Niu L.G.; Zhang M.S.; Liu Y.; Vasorelaxant effect of taurine is diminished by tetraethylammonium in rat isolated arteries. Eur J Pharmacol 2008,580(1-2),169-174","journal-title":"Eur J Pharmacol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1423-0127-17-S1-S2","volume":"17","author":"Schaffer SW","year":"2010","unstructured":"Schaffer SW; Ju Jong C; Kc R; Azuma J; Physiological roles of taurine in heart and muscle. J Biomed Sci 2010,17((Suppl 1)(Suppl. 1)),S2","journal-title":"J Biomed Sci"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1113\/jphysiol.2001.013395","volume":"540","author":"Alfieri R.R.","year":"2002","unstructured":"Alfieri R.R.; Cavazzoni A.; Petronini P.G.; Compatible osmolytes modulate the response of porcine endothelial cells to hypertonicity and protect them from apoptosis. J Physiol 2002,540(2),499-508","journal-title":"J Physiol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12020-019-01931-y","volume":"65","author":"Giugliano D.","year":"2019","unstructured":"Giugliano D.; Maiorino M.I.; Longo M.; Bellastella G.; Chiodini P.; Esposito K.; Type 2 diabetes and risk of heart failure: A systematic review and meta-analysis from cardiovascular outcome trials. Endocrine 2019,65(1),15-24","journal-title":"Endocrine"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejim.2019.01.014","volume":"62","author":"Higuchi S.","year":"2019","unstructured":"Higuchi S.; Kohsaka S.; Shiraishi Y.; Association of renin-angiotensin system inhibitors with long-term outcomes in patients with systolic heart failure and moderate-to-severe kidney function impairment. Eur J Intern Med 2019,62,58-66","journal-title":"Eur J Intern Med"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.2337\/dc18-0831","volume":"41","author":"Cheng Y.J.","year":"2018","unstructured":"Cheng Y.J.; Imperatore G.; Geiss L.S.; Trends and disparities in cardiovascular mortality among U.S. adults with and without self-reported diabetes mellitus 1988\u20132015. Diabetes Care 2018,41(11),2306-2315","journal-title":"Diabetes Care"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"R776","DOI":"10.1152\/ajpregu.00205.2018","volume":"316","author":"Soares D.S.","year":"2019","unstructured":"Soares D.S.; Pinto G.H.; Lopes A.; Cardiac hypertrophy in mice submitted to a swimming protocol: Influence of training volume and intensity on myocardial renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 2019,316(6),R776-R782","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3892\/ijmm.2019.4109","volume":"43","author":"Xiao H.L.","year":"2019","unstructured":"Xiao H.L.; Zhao L.X.; Yang J.; Imbalance of angiotensin-converting enzymes affects myocardial apoptosis during cardiac arrest in-duced by acute pulmonary embolism in a porcine model. Int J Mol Med 2019,43(4),1575-1584","journal-title":"Int J Mol Med"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1389557013407115","volume":"1","author":"Mavromoustakos T.","year":"2001","unstructured":"Mavromoustakos T.; Apostolopoulos V.; Matsoukas J.; Antihypertensive drugs that act on Renin-Angiotensin System with emphasis in AT(1) antagonists. Mini Rev Med Chem 2001,1(2),207-217","journal-title":"Mini Rev Med Chem"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.phrs.2016.07.025","volume":"111","author":"Qaradakhi T.","year":"2016","unstructured":"Qaradakhi T.; Apostolopoulos V.; Zulli A.; Angiotensin (1-7) and Alamandine: Similarities and differences. Pharmacol Res 2016,111,820-826","journal-title":"Pharmacol Res"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/1440-1681.13251","volume":"47","author":"Qaradakhi T.","year":"2020","unstructured":"Qaradakhi T.; Gadanec L.K.; McSweeney K.R.; The potential actions of angiotensin\u2010converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases. Clin Exp Pharmacol Physiol 2020,47(5),751-758","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/ijms17071098","volume":"17","author":"Hrenak J.","year":"2016","unstructured":"Hrenak J.; Paulis L.; Simko F.; Angiotensin A\/Alamandine\/MrgD Axis: Another Clue to Understanding Cardiovascular Pathophysiology. Int J Mol Sci 2016,17(7),1098","journal-title":"Int J Mol Sci"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/00005344-199712000-00004","volume":"30","author":"Takahashi K.","year":"1997","unstructured":"Takahashi K.; Azuma M.; Taira K.; Effect of taurine on angiotensin II-induced hypertrophy of neonatal rat cardiac cells. J Cardiovasc Pharmacol 1997,30(6),725-730","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0014-2999(00)00483-0","volume":"403","author":"Azuma M.","year":"2000","unstructured":"Azuma M.; Takahashi K.; Fukuda T.; Taurine attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac myocytes. Eur J Pharmacol 2000,403(3),181-188","journal-title":"Eur J Pharmacol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/978-1-4615-0077-3_42","volume":"526","author":"Quinn M.R.","year":"2003","unstructured":"Quinn M.R.; Barua M.; Liu Y.; Serban V.; Taurine chloramine inhibits production of inflammatory mediators and iNOS gene expression in alveolar macrophages; a tale of two pathways: Part I, NF-kappaB signaling. Adv Exp Med Biol 2003,526,341-348","journal-title":"Adv Exp Med Biol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jjcc.2011.01.007","volume":"57","author":"Beyranvand M.R.","year":"2011","unstructured":"Beyranvand M.R.; Kadkhodai Khalafi M.; Roshan V.D.; Choobineh S.; Parsa S.A.; Piranfar M.A.; Effect of taurine supplementation on exercise capacity of patients with heart failure. J Cardiol 2011,57(3),333-337","journal-title":"J Cardiol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1021\/jf305157y","volume":"61","author":"Koyama M.","year":"2013","unstructured":"Koyama M.; Naramoto K.; Nakajima T.; Aoyama T.; Watanabe M.; Nakamura K.; Purification and identification of antihypertensive peptides from fermented buckwheat sprouts. J Agric Food Chem 2013,61(12),3013-3021","journal-title":"J Agric Food Chem"},{"key":"ref=110","first-page":"128","volume":"3","author":"Birdsall T.C.","year":"1998","unstructured":"Birdsall T.C.; Therapeutic applications of taurine. Altern Med Rev 1998,3(2),128-136","journal-title":"Altern Med Rev"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1067\/mhj.2002.121927","volume":"143","author":"Jeejeebhoy F.","year":"2002","unstructured":"Jeejeebhoy F.; Keith M.; Freeman M.; Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction. Am Heart J 2002,143(6),1092-1100","journal-title":"Am Heart J"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1253\/jcj.56.95","volume":"56","author":"Azuma J.","year":"1992","unstructured":"Azuma J.; Sawamura A.; Awata N.; Usefulness of taurine in chronic congestive heart failure and its prospective application. Jpn Circ J 1992,56(1),95-99","journal-title":"Jpn Circ J"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/hmg\/ddz303","volume":"29","author":"Ansar M.","year":"2020","unstructured":"Ansar M.; Ranza E.; Shetty M.; Taurine treatment of retinal degeneration and cardiomyopathy in a consanguineous family with SLC6A6 taurine transporter deficiency. Hum Mol Genet 2020,29(4),618-623","journal-title":"Hum Mol Genet"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00726-002-0212-0","volume":"23","author":"Militante J.D.","year":"2002","unstructured":"Militante J.D.; Lombardini J.B.; Treatment of hypertension with oral taurine: Experimental and clinical studies. Amino Acids 2002,23(4),381-393","journal-title":"Amino Acids"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"jimd.12085","DOI":"10.1002\/jimd.12085","volume":"42","author":"Van Hove JLK","year":"2019","unstructured":"Van Hove JLK; Freehauf CL; Ficicioglu C; Biomarkers of oxidative stress, inflammation, and vascular dysfunction in inherited cystathionine \u03b2\u2010synthase deficient homocystinuria and the impact of taurine treatment in a phase 1\/2 human clinical trial. J Inherit Metab Dis 2019,42(3),jimd.12085","journal-title":"J Inherit Metab Dis"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/978-1-4899-0117-0_52","volume":"442","author":"Lima L.","year":"1998","unstructured":"Lima L.; Cubillos S.; Taurine-stimulated outgrowth from the retina is impaired by protein kinase C activators and phosphatase inhibitors. Adv Exp Med Biol 1998,442,423-430","journal-title":"Adv Exp Med Biol"},{"key":"ref=117","first-page":"2673","volume":"18","author":"Ripps H.","year":"2012","unstructured":"Ripps H.; Shen W.; Review: Taurine: A \u201cvery essential\u201d amino acid. Mol Vis 2012,18,2673-2686","journal-title":"Mol Vis"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/0006-8993(72)90523-9","volume":"41","author":"Pasantes-Morales H.","year":"1972","unstructured":"Pasantes-Morales H.; Klethi J.; Ledig M.; Mandel P.; Free amino acids of chicken and rat retina. Brain Res 1972,41(2),494-497","journal-title":"Brain Res"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/j.visres.2004.03.027","volume":"44","author":"Rascher K.","year":"2004","unstructured":"Rascher K.; Servos G.; Berthold G.; Light deprivation slows but does not prevent the loss of photoreceptors in taurine transporter knockout mice. Vision Res 2004,44(17),2091-2100","journal-title":"Vision Res"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/978-94-024-1079-2_54","volume":"975","author":"Hadj-Sa\u00efd W.","year":"2017","unstructured":"Hadj-Sa\u00efd W.; Fradot V.; Ivkovic I.; Sahel J.A.; Picaud S.; Froger N.; Taurine promotes retinal ganglion cell survival through GABAB receptor activation. Adv Exp Med Biol 2017,975(Pt 2),687-701","journal-title":"Adv Exp Med Biol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1167\/iovs.03-0503","volume":"45","author":"El-Sherbeny A.","year":"2004","unstructured":"El-Sherbeny A.; Naggar H.; Miyauchi S.; Osmoregulation of taurine transporter function and expression in retinal pigment epithelial, ganglion, and m\u00fcller cells. Invest Ophthalmol Vis Sci 2004,45(2),694-701","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1023\/A:1015957026924","volume":"234\/235","author":"Ryter S.W.","year":"2002","unstructured":"Ryter S.W.; Otterbein L.E.; Morse D.; Choi A.M.K.; Heme oxygenase\/carbon monoxide signaling pathways: Regulation and functional significance. Mol Cell Biochem 2002,234\/235(1),249-263","journal-title":"Mol Cell Biochem"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"e42017","DOI":"10.1371\/journal.pone.0042017","volume":"7","author":"Froger N.","year":"2012","unstructured":"Froger N.; Cadetti L.; Lorach H.; Taurine provides neuroprotection against retinal ganglion cell degeneration. PLoS One 2012,7(10),e42017","journal-title":"PLoS One"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1167\/iovs.17-23258","volume":"59","author":"Garc\u00eda-Ayuso D.","year":"2018","unstructured":"Garc\u00eda-Ayuso D.; Di Pierdomenico J.; Hadj-Said W.; Taurine Depletion causes ipRGC loss and increases light-induced photoreceptor degeneration. Invest Ophthalmol Vis Sci 2018,59(3),1396-1409","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.2147\/DDDT.S194169","volume":"13","author":"Tao Y.","year":"2019","unstructured":"Tao Y.; He M.; Yang Q.; Systemic taurine treatment provides neuroprotection against retinal photoreceptor degeneration and visual function impairments. Drug Des Devel Ther 2019,13,2689-2702","journal-title":"Drug Des Devel Ther"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.4103\/1673-5374.239450","volume":"13","author":"Agarwal R.","year":"2018","unstructured":"Agarwal R.; Nor Arfuzir N.N.; Iezhitsa I.; Agarwal P.; Sidek S.; Ismail N.; Taurine protects against retinal and optic nerve damage induced by endothelin-1 in rats via antioxidant effects. Neural Regen Res 2018,13(11),2014-2021","journal-title":"Neural Regen Res"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/0005-2736(73)90165-X","volume":"323","author":"Huxtable R.","year":"1973","unstructured":"Huxtable R.; Bressler R.; Effect of taurine on a muscle intracellular membrane. Biochim Biophys Acta Biomembr 1973,323(4),573-583","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF00806821","volume":"8","author":"Schaffer S.W.","year":"1995","unstructured":"Schaffer S.W.; Azuma J.; Madura J.D.; Mechanisms underlying taurine-mediated alterations in membrane function. Amino Acids 1995,8(3),231-246","journal-title":"Amino Acids"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0005-2736(79)90359-6","volume":"551","author":"Chovan J.P.","year":"1979","unstructured":"Chovan J.P.; Kulakowski E.C.; Benson B.W.; Schaffer S.W.; Taurine enhancement of calcium binding to rat heart sarcolemma. Biochim Biophys Acta Biomembr 1979,551(1),129-136","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/00005344-199108000-00008","volume":"18","author":"Hamaguchi T.","year":"1991","unstructured":"Hamaguchi T.; Azuma J.; Schaffer S.; Interaction of taurine with methionine: Inhibition of myocardial phospholipid methyltransferase. J Cardiovasc Pharmacol 1991,18(2),224-230","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref=131","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1023\/A:1017587727533","volume":"131","author":"Sapronov N.S.","year":"2001","unstructured":"Sapronov N.S.; Khnychenko L.K.; Polevshchikov A.V.; Effects of New Taurine Derivatives on Primary Immune Response in Rats Translat-ed from Byulleten Eksperimentalnoi Biologii Meditsiny. Bulletin of Experimental Biology and Medicine 2001,131,142-144","journal-title":"Bulletin of Experimental Biology and Medicine"},{"key":"ref=132","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/00304948609458138","volume":"18","author":"Chanet-Ray J","year":"1986","unstructured":"Chanet-Ray J; Vessiere R; Synthesis and reactions of \u03b2-sultams. A review org prep proced int 1986,18(3),157-78","journal-title":"A review org prep proced int"},{"key":"ref=133","year":"2010","unstructured":"Ross and Wilson Anatomy and Physiology in Health and Illness 2010","journal-title":"Anatomy and Physiology in Health and Illness"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/0-306-46838-7_44","volume":"483","author":"Park E.","year":"2002","unstructured":"Park E.; Quinn M.R.; Schuller-Levis G.; Taurine chloramine attenuates the hydrolytic activity of matrix metalloproteinase-9 in LPS-activated murine peritoneal macrophages. Adv Exp Med Biol 2002,483,389-398","journal-title":"Adv Exp Med Biol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/nass\/1.1.257","volume":"1","author":"Suzuki T.","year":"2001","unstructured":"Suzuki T.; Suzuki T.; Wada T.; Saigo K.; Watanabe K.; Novel taurine-containing uridine derivatives and mitochondrial human diseases. Nucleic Acids Symp Ser 2001,1(1),257-258","journal-title":"Nucleic Acids Symp Ser"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1023\/B:NERE.0000010443.05899.2f","volume":"29","author":"Franconi F.","year":"2004","unstructured":"Franconi F.; Di Leo M.A.S.; Bennardini F.; Ghirlanda G.; Is taurine beneficial in reducing risk factors for diabetes mellitus? Neurochem Res 2004,29(1),143-150","journal-title":"Neurochem Res"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1172\/JCI110652","volume":"70","author":"Weiss S.J.","year":"1982","unstructured":"Weiss S.J.; Klein R.; Slivka A.; Wei M.; Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest 1982,70(3),598-607","journal-title":"J Clin Invest"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/dmrr.229","volume":"17","author":"Hansen S.H.","year":"2001","unstructured":"Hansen S.H.; The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev 2001,17(5),330-346","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"4100106","DOI":"10.1016\/j.fochms.2022.100106","author":"Tao X","year":"2022","unstructured":"Tao X; Zhang Z; Yang Z; Rao B; The effects of taurine supplementation on diabetes mellitus in humans: A systematic review and meta-analysis. Food Chemistry: Molecular Sciences 2022,4100106","journal-title":"Food Chemistry: Molecular Sciences"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/ajcn\/61.5.1115","volume":"61","author":"Franconi F.","year":"1995","unstructured":"Franconi F.; Bennardini F.; Mattana A.; Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: Effects of taurine supplementation. Am J Clin Nutr 1995,61(5),1115-1119","journal-title":"Am J Clin Nutr"},{"key":"ref=141","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/1479164110375971","volume":"7","author":"Moloney M.A.","year":"2010","unstructured":"Moloney M.A.; Casey R.G.; Donnell D.H.O.; Fitzgerald P.; Thompson C.; Bouchier-Hayes D.J.; Two weeks taurine supplementation reverses endothelial dysfunction in young male type 1 diabetic. Diab Vasc Dis Res 2010,7(4),300-310","journal-title":"Diab Vasc Dis Res"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00726-020-02859-8","volume":"52","author":"Maleki V.","year":"2020","unstructured":"Maleki V.; Alizadeh M.; Esmaeili F.; Mahdavi R.; The effects of taurine supplementation on glycemic control and serum lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Amino Acids 2020,52(6-7),905-914","journal-title":"Amino Acids"},{"key":"ref=143","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcjd.2020.05.004","volume":"45","author":"Esmaeili F.","year":"2021","unstructured":"Esmaeili F.; Maleki V.; Kheirouri S.; Alizadeh M.; The effects of taurine supplementation on metabolic profiles, pentosidine, soluble receptor of advanced glycation end products and methylglyoxal in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Canadian J Diabetes 2021,45(1),39-46","journal-title":"Canadian J Diabetes"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12986-022-00684-2","volume":"19","author":"Moludi J.","year":"2022","unstructured":"Moludi J.; Qaisar S.A.; Kadhim M.M.; Ahmadi Y.; Davari M.; Protective and therapeutic effectiveness of taurine supplementation plus low calorie diet on metabolic parameters and endothelial markers in patients with diabetes mellitus: A randomized, clinical trial. Nutr Metab 2022,19(1),49","journal-title":"Nutr Metab"},{"key":"ref=145","first-page":"392","volume":"43","author":"Baskin S.I.","year":"1998","unstructured":"Baskin S.I.; Prabhaharan V.; Bowman J.D.; Novak M.J.;  Effects of Taurine and Thiosulfate on the Spectrophotometric Properties of Rna and Dna Toxicologist 1998,43,392","journal-title":"Effects of Taurine and Thiosulfate on the Spectrophotometric Properties of Rna and Dna Toxicologist"},{"key":"ref=146","first-page":"193","volume":"7","author":"Novak M.J.","year":"1997","unstructured":"Novak M.J.; Baskin S.I.; The effects of inorganic sulfur species on the spec-trophotometric properties of RNA. Toxicol Methods 1997,7,193-206","journal-title":"Toxicol Methods"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/ajcn\/55.3.708","volume":"55","author":"Desai T.K.","year":"1992","unstructured":"Desai T.K.; Maliakkal J.; Kinzie J.L.; Ehrinpreis M.N.; Luk G.D.; Cejka J.; Taurine deficiency after intensive chemotherapy and\/or radiation. Am J Clin Nutr 1992,55(3),708-711","journal-title":"Am J Clin Nutr"},{"key":"ref=148","first-page":"6600","volume":"49","author":"Laidlaw S.A.","year":"1989","unstructured":"Laidlaw S.A.; Dietrich M.F.; Lamtenzan M.P.; Vargas H.I.; Block J.B.; Kopple J.D.; Antimutagenic effects of taurine in a bacterial assay system. Cancer Res 1989,49(23),6600-6604","journal-title":"Cancer Res"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1042\/bj3300939","volume":"330","author":"Cunningham C.","year":"1998","unstructured":"Cunningham C.; Tipton F.K.; Dixon B.F.H.; Conversion of taurine into N-chlorotaurine (taurine chloramine) and sulphoacetaldehyde in response to oxidative stress. Biochem J 1998,330(2),939-945","journal-title":"Biochem J"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/jlb.58.6.667","volume":"58","author":"Marcinkiewicz J.","year":"1995","unstructured":"Marcinkiewicz J.; Grabowska A.; Bereta J.; Stelmaszynska T.; Taurine chloramine, a product of activated neutrophils, inhibits] in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J Leukoc Biol 1995,58(6),667-674","journal-title":"J Leukoc Biol"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/mutage\/7.6.427","volume":"7","author":"Hartley-Asp B.","year":"1992","unstructured":"Hartley-Asp B.; Genotoxicity of tauromustine, a new water soluble taurine-based nitrosourea. I. Mutagenic and clastogenic activity of tauromustine in vitro. Mutagenesis 1992,7(6),427-431","journal-title":"Mutagenesis"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/978-1-4615-0077-3_40","volume":"526","author":"Gupta R.C.","year":"2003","unstructured":"Gupta R.C.; Kim S.J.; Taurine, Analogues and bones. Adv Exp Med Biol 2003,526,323-328","journal-title":"Adv Exp Med Biol"},{"key":"ref=153","first-page":"578","volume":"57","author":"Pushpakiran G.","year":"2005","unstructured":"Pushpakiran G.; Mahalakshmi K.; Viswanathan P.; Anuradh C.V.; Taurine prevents ethanol-induced alterations in lipids and ATPases in rat tissues. Pharmacological Reports 2005,57,578-587","journal-title":"Pharmacological Reports"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.atherosclerosis.2007.12.021","volume":"200","author":"Elvevoll E.O.","year":"2008","unstructured":"Elvevoll E.O.; Eilertsen K.E.; Brox J.; Seafood diets: Hypolipidemic and antiatherogenic effects of taurine and n-3 fatty acids. Atherosclerosis 2008,200(2),396-402","journal-title":"Atherosclerosis"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/hep.22811","volume":"49","author":"Chen X.","year":"2009","unstructured":"Chen X.; Sebastian B.M.; Tang H.; Taurine supplementation prevents ethanol-induced decrease in serum adiponectin and reduces hepatic steatosis in rats. Hepatology 2009,49(5),1554-1562","journal-title":"Hepatology"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"R1710","DOI":"10.1152\/ajpregu.00677.2010","volume":"301","author":"Gentile C.L.","year":"2011","unstructured":"Gentile C.L.; Nivala A.M.; Gonzales J.C.; Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease. Am J Physiol Regul Integr Comp Physiol 2011,301(6),R1710-R1722","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10620-011-1931-4","volume":"57","author":"Hammes T.O.","year":"2012","unstructured":"Hammes T.O.; Pedroso G.L.; Hartmann C.R.; The effect of taurine on hepatic steatosis induced by thioacetamide in zebrafish (Danio rerio). Dig Dis Sci 2012,57(3),675-682","journal-title":"Dig Dis Sci"},{"key":"ref=158","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/978-3-319-15126-7_64","volume":"803","author":"Wu G.","year":"2015","unstructured":"Wu G.; Tang R.; Yang J.; Taurine accelerates alcohol and fat metabolism of rats with alcoholic Fatty liver disease. Adv Exp Med Biol 2015,803,793-805","journal-title":"Adv Exp Med Biol"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"e0144509","DOI":"10.1371\/journal.pone.0144509","volume":"10","author":"Abdel-Moneim A.M.","year":"2015","unstructured":"Abdel-Moneim A.M.; Al-Kahtani M.A.; El-Kersh M.A.; Al-Omair M.A.; Free radical-scavenging, anti-inflammatory\/anti-fibrotic and hepato-protective actions of taurine and silymarin against CCl4 induced rat liver damage. PLoS One 2015,10(12),e0144509","journal-title":"PLoS One"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s00726-018-2605-8","volume":"50","author":"Murakami S.","year":"2018","unstructured":"Murakami S.; Ono A.; Kawasaki A.; Takenaga T.; Ito T.; Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro. Amino Acids 2018,50(9),1279-1288","journal-title":"Amino Acids"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"e42935","DOI":"10.1371\/journal.pone.0042935","volume":"7","author":"Shivaraj M.C.","year":"2012","unstructured":"Shivaraj M.C.; Marcy G.; Low G.; Taurine induces proliferation of neural stem cells and synapse development in the developing mouse brain. PLoS One 2012,7(8),e42935","journal-title":"PLoS One"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.scr.2012.02.004","volume":"9","author":"Hern\u00e1ndez-Ben\u00edtez R.","year":"2012","unstructured":"Hern\u00e1ndez-Ben\u00edtez R.; Ramos-Mandujano G.; Pasantes-Morales H.; Taurine stimulates proliferation and promotes neurogenesis of mouse adult cultured neural stem\/progenitor cells. Stem Cell Res (Amst) 2012,9(1),24-34","journal-title":"Stem Cell Res (Amst)"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.scr.2015.04.001","volume":"14","author":"Gebara E.","year":"2015","unstructured":"Gebara E.; Udry F.; Sultan S.; Toni N.; Taurine increases hippocampal neurogenesis in aging mice. Stem Cell Res (Amst) 2015,14(3),369-379","journal-title":"Stem Cell Res (Amst)"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"225","DOI":"10.4062\/biomolther.2017.251","volume":"26","author":"Schaffer S.","year":"2018","unstructured":"Schaffer S.; Kim H.W.; Effects and mechanisms of taurine as a therapeutic agent. Biomol Ther (Seoul) 2018,26(3),225-241","journal-title":"Biomol Ther (Seoul)"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0014-2999(85)90746-0","volume":"113","author":"Mattucci-Schiavone L.","year":"1985","unstructured":"Mattucci-Schiavone L.; Ferko A.P.; Acute effects of taurine and a taurine antagonist on ethanol-induced central nervous system depression. Eur J Pharmacol 1985,113(2),275-278","journal-title":"Eur J Pharmacol"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1038\/s41598-017-05051-3","volume":"7","author":"Wu G.F.","year":"2017","unstructured":"Wu G.F.; Ren S.; Tang R.Y.; Antidepressant effect of taurine in chronic unpredictable mild stress-induced depressive rats. Sci Rep 2017,7(1),4989-9","journal-title":"Sci Rep"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-0-387-75681-3_21","volume":"643","author":"Idrissi A.E.","year":"2009","unstructured":"Idrissi A.E.; Boukarrou L.; Heany W.; Malliaros G.; Sangdee C.; Neuwirth L.; Effects of taurine on anxiety-like and locomotor behavior of mice. Adv Exp Med Biol 2009,643,207-215","journal-title":"Adv Exp Med Biol"},{"key":"ref=168","first-page":"1089","volume":"2","author":"Zhu Y.","year":"2022","unstructured":"Zhu Y.; Wang R.; Fan Z.; Luo D.; Cai G.; Taurine Alleviates Chronic Social Defeat Stress-Induced Depression by Protecting Cortical Neurons from Dendritic Spine Loss. Cell Mol Neurobiol 2022,2,1089","journal-title":"Cell Mol Neurobiol"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jobaz.2015.02.001","volume":"72","author":"Noor N.A.","year":"2015","unstructured":"Noor N.A.; Mohammed H.S.; Khadrawy Y.A.; Aboul Ezz H.S.; Radwan N.M.; Evaluation of the neuroprotective effect of taurine and green tea extract against oxidative stress induced by pilocarpine during status epilepticus. J Basic Appl Zool 2015,72,8-15","journal-title":"J Basic Appl Zool"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/jnr.490060404","volume":"6","author":"Pasantes-Morales H.","year":"1981","unstructured":"Pasantes-Morales H.; Arzate M.E.; Effect of taurine on seizures induced by 4-aminopyridine. J Neurosci Res 1981,6(4),465-474","journal-title":"J Neurosci Res"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1002\/jnr.21950","volume":"87","author":"Junyent F.","year":"2009","unstructured":"Junyent F.; Utrera J.; Romero R.; Prevention of epilepsy by taurine treatments in mice experimental model. J Neurosci Res 2009,87(6),1500-1508","journal-title":"J Neurosci Res"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/978-1-4615-0077-3_62","volume":"526","author":"El Idrissi A.","year":"2003","unstructured":"El Idrissi A.; Messing J.; Scalia J.; Trenkner E.; Prevention of epileptic seizures by taurine. Adv Exp Med Biol 2003,526,515-525","journal-title":"Adv Exp Med Biol"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijep.2017.07.001","volume":"4","author":"Kumar S.","year":"2017","unstructured":"Kumar S.; Goel R.; Taurine supplementation to anti-seizure drugs as the promising approach to treat pharmacoresistant epilepsy: A pre-clinical study. Int J Epilepsy 2017,4(2),119-124","journal-title":"Int J Epilepsy"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00726-005-0196-7","volume":"28","author":"Bittner S.","year":"2005","unstructured":"Bittner S.; Win T.; Gupta R.; \u03b3-L-glutamyltaurine. Amino Acids 2005,28(4),343-356","journal-title":"Amino Acids"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"16555","DOI":"10.1038\/s41598-018-32733-3","volume":"8","author":"Tian J.","year":"2018","unstructured":"Tian J.; Dang H.; Wallner M.; Olsen R.; Kaufman D.L.; Homotaurine, a safe blood-brain barrier permeable GABAA-R-specific agonist, ameliorates disease in mouse models of multiple sclerosis. Sci Rep 2018,8(1),16555-5","journal-title":"Sci Rep"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1600-0773.1985.tb00016.x","volume":"57","author":"Ahtee L.","year":"1985","unstructured":"Ahtee L.; Auvinen H.; M\u00e4enp\u00e4 A.R.; Vahala M.L.; Lehtinen M.; Halmckoski J.; Comparison of central nervous system actions of taurine and N-pivaloyltaurine. Acta Pharmacol Toxicol (Copenh) 1985,57(2),96-105","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10517-006-0089-0","volume":"141","author":"Sapronov N.S.","year":"2006","unstructured":"Sapronov N.S.; Bul\u2019on V.V.; Krylova I.B.; Gavrovskaya L.K.; Selina E.N.; Evdokimova N.R.; Cerebroprotective effect of a new taurine derivative during cerebral ischemia. Bull Exp Biol Med 2006,141(1),44-47","journal-title":"Bull Exp Biol Med"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.bcp.2006.02.007","volume":"71","author":"Ricci L.","year":"2006","unstructured":"Ricci L.; Frosini M.; Gaggelli N.; Inhibition of rabbit brain 4-aminobutyrate transaminase by some taurine analogues: A kinetic analysis. Biochem Pharmacol 2006,71(10),1510-1519","journal-title":"Biochem Pharmacol"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0028-3908(87)90039-6","volume":"26","author":"Kontro P.","year":"1987","unstructured":"Kontro P.; Oja S.S.; Effects of the anticonvulsant taurine derivative, taltrimide, on membrane transport and binding of GABA and taurine in the mouse cerebrum. Neuropharmacology 1987,26(1),19-23","journal-title":"Neuropharmacology"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1016\/j.bmcl.2017.09.055","volume":"27","author":"Sang Z.","year":"2017","unstructured":"Sang Z.; Wang K.; Wang H.; Design, synthesis and biological evaluation of phthalimide-alkylamine derivatives as balanced multi-functional cholinesterase and monoamine oxidase-B inhibitors for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem Lett 2017,27(22),5053-5059","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=181","first-page":"1","author":"Bick K.","year":"1907","unstructured":"Bick K.; Amaducci L.; Pepeu G.; Alzheimer A characteristic disease of the cerebral cortex.The early story of Alzheimer\u2019s disease. 1907,1-3"},{"key":"ref=182","unstructured":"Alzheimer\u2019s disease Education and Referral Center Web site Alzheimer\u2019s disease-unraveling the mystery  http:\/\/www.nia nih.gov\/alzheimers\/publication\/alzheimers-disease-unravelingmystery\/prefac","journal-title":"Alzheimer\u2019s disease-unraveling the mystery"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/0166-2236(87)90173-1","volume":"10","author":"MacDermott A.B.","year":"1987","unstructured":"MacDermott A.B.; Dale N.; Receptors, ion channels and synaptic potentials underlying the integrative actions of excitatory amino acids. Trends Neurosci 1987,10(7),280-284","journal-title":"Trends Neurosci"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-3-7091-6467-9_11","volume":"53","author":"Braak H.","year":"1998","unstructured":"Braak H.; Braak E.; Evolution of neuronal changes in the course of Alzheimer\u2019s disease. J Neural Transm Suppl 1998,53,127-140","journal-title":"J Neural Transm Suppl"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S0021-9258(18)48529-8","volume":"267","author":"Burdick D.","year":"1992","unstructured":"Burdick D.; Soreghan B.; Kwon M.; Assembly and aggregation properties of synthetic Alzheimer\u2019s A4\/beta amyloid peptide analogs. J Biol Chem 1992,267(1),546-554","journal-title":"J Biol Chem"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/0092-8674(93)90312-E","volume":"75","author":"Haass C.","year":"1993","unstructured":"Haass C.; Selkoe D.J.; Cellular processing of \u03b2-amyloid precursor protein and the genesis of amyloid \u03b2-peptide. Cell 1993,75(6),1039-1042","journal-title":"Cell"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/sj.emboj.7600061","volume":"23","author":"Haass C.","year":"2004","unstructured":"Haass C.; Take five-BACE and the c-secretase quartet conduct Alzheimer\u2019s amyloid b-peptide generation. EMBO J 2004,23(3),483-488","journal-title":"EMBO J"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1126\/science.286.5441.916","volume":"286","author":"Haass C.","year":"1999","unstructured":"Haass C.; Strooper B.D.; The presenilins in Alzheimer\u2019s disease--proteolysis holds the key. Science 1999,286(5441),916-919","journal-title":"Science"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"Selkoe D.J.","year":"2002","unstructured":"Selkoe D.J.; Alzheimer\u2019s disease is a synaptic failure. Science 2002,298(5594),789-791","journal-title":"Science"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"11061","DOI":"10.1523\/JNEUROSCI.3034-05.2005","volume":"25","author":"Roselli F.","year":"2005","unstructured":"Roselli F.; Tirard M.; Lu J.; Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. J Neurosci 2005,25(48),11061-11070","journal-title":"J Neurosci"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"Lesn\u00e9 S.","year":"2006","unstructured":"Lesn\u00e9 S.; Koh M.T.; Kotilinek L.; A specific amyloid-\u03b2 protein assembly in the brain impairs memory. Nature 2006,440(7082),352-357","journal-title":"Nature"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"Haass C.","year":"2007","unstructured":"Haass C.; Selkoe D.J.; Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer\u2019s amyloid \u03b2-peptide. Nat Rev Mol Cell Biol 2007,8(2),101-112","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","volume":"27","author":"Shankar G.M.","year":"2007","unstructured":"Shankar G.M.; Bloodgood B.L.; Townsend M.; Walsh D.M.; Selkoe D.J.; Sabatini B.L.; Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 2007,27(11),2866-2875","journal-title":"J Neurosci"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"Shankar G.M.","year":"2008","unstructured":"Shankar G.M.; Li S.; Mehta T.H.; Amyloid-\u03b2 protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med 2008,14(8),837-842","journal-title":"Nat Med"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/13506120500106958","volume":"12","author":"Bitan G.","year":"2005","unstructured":"Bitan G.; Fradinger E.A.; Spring S.M.; Teplow D.B.; Neurotoxic protein oligomers \u2014 what you see is not always what you get. Amyloid 2005,12(2),88-95","journal-title":"Amyloid"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1523\/JNEUROSCI.2381-04.2005","volume":"25","author":"Wogulis M.","year":"2005","unstructured":"Wogulis M.; Wright S.; Cunningham D.; Chilcote T.; Powell K.; Rydel R.E.; Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death. J Neurosci 2005,25(5),1071-1080","journal-title":"J Neurosci"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"15157","DOI":"10.1021\/bi061850f","volume":"45","author":"Hepler R.W.","year":"2006","unstructured":"Hepler R.W.; Grimm K.M.; Nahas D.D.; Solution state characterization of amyloid beta-derived diffusible ligands. Biochemistry 2006,45(51),15157-15167","journal-title":"Biochemistry"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1038\/emboj.2010.211","volume":"29","author":"Kuperstein I.","year":"2010","unstructured":"Kuperstein I.; Broersen K.; Benilova I.; Neurotoxicity of Alzheimer\u2019s disease A\u03b2 peptides is induced by small changes in the A\u03b242 to A\u03b240 ratio. EMBO J 2010,29(19),3408-3420","journal-title":"EMBO J"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0022-510X(00)00467-6","volume":"182","author":"Sze C.I.","year":"2001","unstructured":"Sze C.I.; Bi H.; Kleinschmidt-DeMasters B.K.; Filley C.M.; Martin L.J.; N-Methyl-d-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer\u2019s disease. J Neurol Sci 2001,182(2),151-159","journal-title":"J Neurol Sci"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00702-006-0579-2","volume":"113","author":"Schliebs R.","year":"2006","unstructured":"Schliebs R.; Arendt T.; The significance of the cholinergic system in the brain during aging and in Alzheimer\u2019s disease. J Neural Transm (Vienna) 2006,113(11),1625-1644","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2004.06.015","volume":"225","author":"Teaktong T.","year":"2004","unstructured":"Teaktong T.; Graham A.J.; Court J.A.; Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer\u2019s disease and dementia with Lewy bodies: Differential neuronal and astroglial pathology. J Neurol Sci 2004,225(1-2),39-49","journal-title":"J Neurol Sci"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/NEN.0b013e31816a1df3","volume":"67","author":"Geula C.","year":"2008","unstructured":"Geula C.; Nagykery N.; Nicholas A.; Wu C.K.; Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease. J Neuropathol Exp Neurol 2008,67(4),309-318","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2009.09.007","volume":"491","author":"Kumar R.","year":"2009","unstructured":"Kumar R.; Role of naturally occurring osmolytes in protein folding and stability. Arch Biochem Biophys 2009,491(1-2),1-6","journal-title":"Arch Biochem Biophys"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1523\/JNEUROSCI.21-12-04125.2001","volume":"21","author":"Dineley K.T.","year":"2001","unstructured":"Dineley K.T.; Westerman M.; Bui D.; Bell K.; Ashe K.H.; Sweatt J.D.; Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors:] in vitro and in vivo mechanisms related to Alzheimer\u2019s disease. J Neurosci 2001,21(12),4125-4133","journal-title":"J Neurosci"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev.ne.19.030196.002253","volume":"19","author":"Bear M.F.","year":"1996","unstructured":"Bear M.F.; Abraham W.C.; Long-term depression in hippocampus. Annu Rev Neurosci 1996,19(1),437-462","journal-title":"Annu Rev Neurosci"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1126\/science.8389057","volume":"260","author":"Frey U.","year":"1993","unstructured":"Frey U.; Huang Y.Y.; Kandel E.R.; Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 1993,260(5114),1661-1664","journal-title":"Science"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0092-8674(00)80896-X","volume":"92","author":"Winder D.G.","year":"1998","unstructured":"Winder D.G.; Mansuy I.M.; Osman M.; Moallem T.M.; Kandel E.R.; Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin. Cell 1998,92(1),25-37","journal-title":"Cell"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1523\/JNEUROSCI.19-13-05683.1999","volume":"19","author":"Schulz S.","year":"1999","unstructured":"Schulz S.; Siemer H.; Krug M.; H\u00f6llt V.; Direct evidence for biphasic cAMP responsive element-binding protein phosphorylation during long-term potentiation in the rat dentate gyrus in vivo. J Neurosci 1999,19(13),5683-5692","journal-title":"J Neurosci"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0361-9230(00)00370-1","volume":"53","author":"Kawahara M.","year":"2000","unstructured":"Kawahara M.; Kuroda Y.; Molecular mechanism of neurodegeneration induced by Alzheimer\u2019s \u03b2-amyloid protein: Channel formation and disruption of calcium homeostasis. Brain Res Bull 2000,53(4),389-397","journal-title":"Brain Res Bull"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1096\/fj.01-0377com","volume":"15","author":"Lin H.","year":"2001","unstructured":"Lin H.; Bhatia R.; Lal R.; Amyloid \u03b2 protein forms ion channels: Implications for Alzheimer\u2019s disease pathophysiology. FASEB J 2001,15(13),2433-2444","journal-title":"FASEB J"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/exnr.1994.1107","volume":"128","author":"Goodman Y.","year":"1994","unstructured":"Goodman Y.; Mattson M.P.; Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp Neurol 1994,128(1),1-12","journal-title":"Exp Neurol"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0006-8993(83)91266-0","volume":"259","author":"Okamoto K.","year":"1983","unstructured":"Okamoto K.; Kimura H.; Sakai Y.; Taurine-induced increase of the Cl-conductance of cerebellar Purkinje cell dendrites in vitro. Brain Res 1983,259(2),319-323","journal-title":"Brain Res"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s11064-005-8986-6","volume":"30","author":"Albrecht J.","year":"2005","unstructured":"Albrecht J.; Schousboe A.; Taurine interaction with neurotransmitter receptors in the CNS: An update. Neurochem Res 2005,30(12),1615-1621","journal-title":"Neurochem Res"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1096\/fj.03-0739com","volume":"18","author":"Louzada P.R.","year":"2004","unstructured":"Louzada P.R.; Lima A.C.P.; Mendonca-Silva D.L.; No\u00ebl F.; De Mello F.G.; Ferreira S.T.; Taurine prevents the neurotoxicity of \u03b2\u2010amyloid and glutamate receptor agonists: Activation of GABA receptors and possible implications for Alzheimer\u2019s disease and other neurological dis-orders. FASEB J 2004,18(3),511-518","journal-title":"FASEB J"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.neuropharm.2005.06.015","volume":"49","author":"Paula-Lima A.C.","year":"2005","unstructured":"Paula-Lima A.C.; De Felice F.G.; Brito-Moreira J.; Ferreira S.T.; Activation of GABAA receptors by taurine and muscimol blocks the neurotoxicity of \u03b2-amyloid in rat hippocampal and cortical neurons. Neuropharmacology 2005,49(8),1140-1148","journal-title":"Neuropharmacology"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/978-1-4899-0405-8_28","volume":"217","author":"Wu J.Y.","year":"1987","unstructured":"Wu J.Y.; Johansen F.F.; Lin C.T.; Liu J.W.; Taurine system in the normal and ischemic rat hippocampus. Adv Exp Med Biol 1987,217,265-274","journal-title":"Adv Exp Med Biol"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/0-306-46838-7_4","volume":"483","author":"Wu J.Y.","year":"2002","unstructured":"Wu J.Y.; Chen W.; Tang X.W.; Mode of action of taurine and regulation dynamics of its synthesis in the CNS. Adv Exp Med Biol 2002,483,35-44","journal-title":"Adv Exp Med Biol"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.brainres.2005.01.058","volume":"1038","author":"Wu H.","year":"2005","unstructured":"Wu H.; Jin Y.; Wei J.; Jin H.; Sha D.; Wu J.Y.; Mode of action of taurine as a neuroprotector. Brain Res 2005,1038(2),123-131","journal-title":"Brain Res"},{"key":"ref=219","first-page":"403","author":"Tang X.W.","year":"1963","unstructured":"Tang X.W.; Deupree D.L.; Sun Y.; Wu J.Y.;  Biphasic effect of taurine on excitatory amino acid-induced neurotoxicityTaurine 2 Advances in Experimental Medicine and Biology 1963,403","journal-title":"Biphasic effect of taurine on excitatory amino acid-induced neurotoxicityTaurine 2 Advances in Experimental Medicine and Biology"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00726-006-0396-9","volume":"34","author":"El Idrissi A.","year":"2008","unstructured":"El Idrissi A.; Taurine increases mitochondrial buffering of calcium: Role in neuroprotection. Amino Acids 2008,34(2),321-328","journal-title":"Amino Acids"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neulet.2007.09.068","volume":"429","author":"Santa-Mar\u00eda I.","year":"2007","unstructured":"Santa-Mar\u00eda I.; Hern\u00e1ndez F.; Moreno F.J.; Avila J.; Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid-\u03b2-peptide aggregation. Neurosci Lett 2007,429(2-3),91-94","journal-title":"Neurosci Lett"},{"key":"ref=222","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.1038\/srep07467","volume":"4","author":"Kim H.Y.","year":"2014","unstructured":"Kim H.Y.; Kim H.V.; Yoon J.H.; Kang B.R.; Cho S.M.; Lee S.; Taurine in drinking water recovers learning and memory in the adult APP\/PS1 mouse model of Alzheimer\u2019s disease. Sci Rep 2014,4,7467","journal-title":"Sci Rep"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"132109356","DOI":"10.1016\/j.mehy.2019.109356","author":"McCarty M.F.","year":"2019","unstructured":"McCarty M.F.; O\u2019Keefe J.H.; DiNicolantonio J.J.; A diet rich in taurine, cysteine, folate, B12 and betaine may lessen risk for Alzheimer\u2019s disease by boosting brain synthesis of hydrogen sulfide. Med Hypotheses 2019,132109356","journal-title":"Med Hypotheses"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"15551","DOI":"10.1038\/s41598-020-72755-4","volume":"10","author":"Oh S.J.","year":"2020","unstructured":"Oh S.J.; Lee H.J.; Jeong Y.J.; Evaluation of the neuroprotective effect of taurine in Alzheimer\u2019s disease using functional molecular imaging. Sci Rep 2020,10(1),15551","journal-title":"Sci Rep"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/alz.058642","volume":"17","author":"Abdulkadir T.S.","year":"2021","unstructured":"Abdulkadir T.S.; Isa A.S.; Dawud F.A.; Ayo J.O.; Mohammed M.D.; Effect of taurine and camel milk on amyloid beta peptide concentration and oxidative stress changes in aluminium chloride\u2010induced Alzheimer\u2019s disease rats. Alzheimers Dement 2021,17(S12),12","journal-title":"Alzheimers Dement"},{"key":"ref=226","author":"Rossato RC","year":"2021","unstructured":"Rossato RC; Granato AEC; Pinto JC; Moraes CDGDO; Salles GN; Soares CP; Neuroprotective effects of taurine on SH-SY5Y cells under hydrocortisone induced stress. Research, Society and Development 2021","journal-title":"Research, Society and Development"}],"container-title":["Current Drug Discovery Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570163820666230525101353","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/217306\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570163820666230525101353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T11:49:32Z","timestamp":1699616972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/217306\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":226,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570163820666230525101353","relation":{},"ISSN":["1570-1638"],"issn-type":[{"value":"1570-1638","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-12-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e250523217306"}}